These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38950084)

  • 1. Circulating Metabolite Profiles and Risk of Coronary Heart Disease Among Racially and Geographically Diverse Populations.
    Deng K; Gupta DK; Shu XO; Lipworth L; Zheng W; Cai H; Cai Q; Yu D
    Circ Genom Precis Med; 2024 Aug; 17(4):e004437. PubMed ID: 38950084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Lipids, Lipoproteins, and Apolipoproteins With Risk of Coronary Heart Disease: A Prospective Study Among Racially Diverse Populations.
    Deng K; Pan XF; Voehler MW; Cai Q; Cai H; Shu XO; Gupta DK; Lipworth L; Zheng W; Yu D
    J Am Heart Assoc; 2024 May; 13(10):e034364. PubMed ID: 38726919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolite Signature of Life's Essential 8 and Risk of Coronary Heart Disease Among Low-Income Black and White Americans.
    Deng K; Gupta DK; Shu XO; Lipworth L; Zheng W; Thomas VE; Cai H; Cai Q; Wang TJ; Yu D
    Circ Genom Precis Med; 2023 Dec; 16(6):e004230. PubMed ID: 38014580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic Analysis of Coronary Heart Disease in an African American Cohort From the Jackson Heart Study.
    Cruz DE; Tahir UA; Hu J; Ngo D; Chen ZZ; Robbins JM; Katz D; Balasubramanian R; Peterson B; Deng S; Benson MD; Shi X; Dailey L; Gao Y; Correa A; Wang TJ; Clish CB; Rexrode KM; Wilson JG; Gerszten RE
    JAMA Cardiol; 2022 Feb; 7(2):184-194. PubMed ID: 34851361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic Effects of Hormone Therapy and Associations With Coronary Heart Disease Among Postmenopausal Women.
    Balasubramanian R; Demler O; Guasch-Ferré M; Paynter NP; Sheehan R; Liu S; Manson JE; Salas-Salvadó J; Martínez-Gonzalez MÁ; Hu FB; Clish C; Rexrode KM
    Circ Genom Precis Med; 2020 Dec; 13(6):e002977. PubMed ID: 33141616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic Pattern Predicts Incident Coronary Heart Disease.
    Wang Z; Zhu C; Nambi V; Morrison AC; Folsom AR; Ballantyne CM; Boerwinkle E; Yu B
    Arterioscler Thromb Vasc Biol; 2019 Jul; 39(7):1475-1482. PubMed ID: 31092011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A metabolomic profile is associated with the risk of incident coronary heart disease.
    Vaarhorst AA; Verhoeven A; Weller CM; Böhringer S; Göraler S; Meissner A; Deelder AM; Henneman P; Gorgels AP; van den Brandt PA; Schouten LJ; van Greevenbroek MM; Merry AH; Verschuren WM; van den Maagdenberg AM; van Dijk KW; Isaacs A; Boomsma D; Oostra BA; van Duijn CM; Jukema JW; Boer JM; Feskens E; Heijmans BT; Slagboom PE
    Am Heart J; 2014 Jul; 168(1):45-52.e7. PubMed ID: 24952859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary metabolites and risk of coronary heart disease: A prospective investigation among urban Chinese adults.
    Yoon HS; Jeong Yang J; Rivera ES; Shu XO; Xiang YB; Calcutt MW; Cai Q; Zhang X; Li H; Gao YT; Zheng W; Yu D
    Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):467-473. PubMed ID: 31831367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Metabolomic Profiles Between Black and White Women and Risk of Coronary Heart Disease: an Observational Study of Women From Four US Cohorts.
    Hu J; Yao J; Deng S; Balasubramanian R; Jiménez MC; Li J; Guo X; Cruz DE; Gao Y; Huang T; Zeleznik OA; Ngo D; Liu S; Rosal MC; Nassir R; Paynter NP; Albert CM; Tracy RP; Durda P; Liu Y; Taylor KD; Johnson WC; Sun Q; Rimm EB; Eliassen AH; Rich SS; Rotter JI; Gerszten RE; Clish CB; Rexrode KM
    Circ Res; 2022 Sep; 131(7):601-615. PubMed ID: 36052690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.
    Cavus E; Karakas M; Ojeda FM; Kontto J; Veronesi G; Ferrario MM; Linneberg A; Jørgensen T; Meisinger C; Thorand B; Iacoviello L; Börnigen D; Woodward M; Schnabel R; Costanzo S; Tunstall-Pedoe H; Koenig W; Kuulasmaa K; Salomaa V; Blankenberg S; Zeller T;
    JAMA Cardiol; 2019 Dec; 4(12):1270-1279. PubMed ID: 31664431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CD14, Ischemic Stroke, and Coronary Heart Disease Risk in a Prospective Study: The REGARDS Cohort.
    Olson NC; Koh I; Reiner AP; Judd SE; Irvin MR; Howard G; Zakai NA; Cushman M
    J Am Heart Assoc; 2020 Mar; 9(6):e014241. PubMed ID: 32157955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary flavonoid intake and incident coronary heart disease: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.
    Goetz ME; Judd SE; Safford MM; Hartman TJ; McClellan WM; Vaccarino V
    Am J Clin Nutr; 2016 Nov; 104(5):1236-1244. PubMed ID: 27655439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Habitual sleep quality, plasma metabolites and risk of coronary heart disease in post-menopausal women.
    Huang T; Zeleznik OA; Poole EM; Clish CB; Deik AA; Scott JM; Vetter C; Schernhammer ES; Brunner R; Hale L; Manson JE; Hu FB; Redline S; Tworoger SS; Rexrode KM
    Int J Epidemiol; 2019 Aug; 48(4):1262-1274. PubMed ID: 30371783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Levels of Trimethylamine-N-Oxide and Incident Coronary Heart Disease: A Prospective Investigation Among Urban Chinese Adults.
    Yu D; Shu XO; Rivera ES; Zhang X; Cai Q; Calcutt MW; Xiang YB; Li H; Gao YT; Wang TJ; Zheng W
    J Am Heart Assoc; 2019 Jan; 8(1):e010606. PubMed ID: 30606084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolite Signature of Life's Essential 8 and Risk of Coronary Heart Disease among Low-Income Black and White Americans.
    Deng K; Gupta DK; Shu XO; Lipworth L; Zheng W; Thomas VE; Cai H; Cai Q; Wang TJ; Yu D
    medRxiv; 2023 May; ():. PubMed ID: 37163035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: Multi-Ethnic Study of Atherosclerosis.
    Yeboah J; McNamara C; Jiang XC; Tabas I; Herrington DM; Burke GL; Shea S
    Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):628-33. PubMed ID: 20032291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte Telomere Length and Risks of Incident Coronary Heart Disease and Mortality in a Racially Diverse Population of Postmenopausal Women.
    Carty CL; Kooperberg C; Liu J; Herndon M; Assimes T; Hou L; Kroenke CH; LaCroix AZ; Kimura M; Aviv A; Reiner AP
    Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2225-31. PubMed ID: 26249011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Predictors of Incident Coronary Heart Disease in Women.
    Paynter NP; Balasubramanian R; Giulianini F; Wang DD; Tinker LF; Gopal S; Deik AA; Bullock K; Pierce KA; Scott J; Martínez-González MA; Estruch R; Manson JE; Cook NR; Albert CM; Clish CB; Rexrode KM
    Circulation; 2018 Feb; 137(8):841-853. PubMed ID: 29459470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease.
    Ganna A; Salihovic S; Sundström J; Broeckling CD; Hedman AK; Magnusson PK; Pedersen NL; Larsson A; Siegbahn A; Zilmer M; Prenni J; Arnlöv J; Lind L; Fall T; Ingelsson E
    PLoS Genet; 2014 Dec; 10(12):e1004801. PubMed ID: 25502724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining serum metabolomic profiles with traditional risk factors improves 10-year cardiovascular risk prediction in people with type 2 diabetes.
    Huang Z; Klaric L; Krasauskaite J; Khalid W; Strachan MWJ; Wilson JF; Price JF
    Eur J Prev Cardiol; 2023 Sep; 30(12):1255-1262. PubMed ID: 37172216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.